Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 10 | 0 | 0 | 0 |
| Receivables | N/A | N/A | N/A | N/A | 1 |
| TOTAL | $0 | $10 | $0 | $0 | $1 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1 | 1 |
| Intangibles | 0 | 0 | 1 | 0 | 0 |
| TOTAL | $0 | $0 | $1 | $1 | $1 |
| Total Assets | $0 | $10 | $1 | $1 | $2 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15 | 23 | 18 | 5 | 9 |
| TOTAL | $15 | $23 | $18 | $5 | $9 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 7 | 2 |
| TOTAL | $N/A | $N/A | $N/A | $7 | $2 |
| Total Liabilities | $15 | $23 | $18 | $12 | $10 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31 | 31 | 31 | 30 | 30 |
| Common Shares | 130 | 130 | 120 | 120 | 120 |
| Retained earnings | -227 | -220 | -211 | -200 | -193 |
| Other shareholders' equity | 21 | 21 | 21 | 21 | 21 |
| TOTAL | $-15 | $-13 | $-17 | $-11 | $-9 |
| Total Liabilities And Equity | $0 | $10 | $1 | $1 | $2 |